Cognition and cannabis: From anecdote to advanced technology

Brain

Volumn 135, Issue 7, 2012, Pages 2004-2005

  Brust, John C M ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABIS;

BRAIN DEVELOPMENT; COGNITION; COGNITIVE DEFECT; DIFFUSION WEIGHTED IMAGING; DRUG USE; EXECUTIVE FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; INTELLIGENCE QUOTIENT; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NOTE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RECEPTOR DENSITY; RISK FACTOR; SCHIZOPHRENIA; TECHNOLOGY; VERBAL BEHAVIOR; WORKING MEMORY;

EID: 84863198801     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws165     Document Type: Note

References (17)

1. Ashtari M, Cervellione K, Cottone J, Ardekani BA, Sevy S, Kumra S. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. J Psychiatr Res 2009; 43: 189-204.
2. Block RI, Ghonheim MM. Effects of chronic marijuana use on human cognition. Psychopharmacology 1993; 110: 219-28. (Pubitemid 23029454)
3. Bolla KI, Brown K, Eldreth BA, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology 2002; 59: 1337-43. (Pubitemid 35285983)
4. Bolla KI, Eldreth DA, Matochik JA, Cadet JL. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 2005; 26: 480-92. (Pubitemid 40719826)
5. Chang L, Yakupov R, Cloak C, Ernst T. Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain 2006; 129: 1096-112.
6. Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage 2012; 59: 3845-51.
7. Eldreth DA, Matochik JA, Cadet JL, Bolla KI. Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage 2004; 23: 914-20. (Pubitemid 39446525)
8. Fernandez-Espejo E, Viveros M-P, Nunez L, Ellenbroek BA, Rodriguez de Fonseca F. Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology 2009; 206: 531-49.
9. Fried P, Watkinson B, James D, Gray R. Current and former marijuana use: preliminary findings in a longitudinal study of effects on IQ in young adults. Can Med Assoc J 2002; 166: 887-91. (Pubitemid 34275508)
10. Harkany T, Guzman M, Galve-Raperh I, Berghuis P, Devi LA, Mackie K. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 2007; 28: 83-92. (Pubitemid 46161836)
11. Jager G, Van Hell HH, DeWin MM, Kahn RS, Van Den Brink W, Van Ree JM, et al. Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur Neuropsychopharmacol 2007; 17: 289-97. (Pubitemid 46156994)
12. Le Bec PY, Fatseas M, Denis C, Lavie E, Auriacombe M. Cannabis and psychosis: search for a causal link through a critical and systematic review. Encephale 2009; 35: 377-85.
13. Leweke FM, Giuffrida A, Wurseter V, Emrich HM, Piomelli D. Elevated endogenous cannabinoids in schizophrenia. Neuroreport 1999; 10: 1665-9. (Pubitemid 29354290)
14. Lorenzetti V, Lubman DI, Whittle S, Solowij N, Yucel M. Structural MRI findings in long-term cannabis users: what do we know? Subst Use Misuse 2010; 45: 1787-808.
15. Smith AM, Fried PA, Hogan MJ, Cameron I. Effects of prenatal marijuana on visuospatial working memory: an fMRI study in young adults. Neurotoxicol Teratol 2006; 28: 286-95.
16. Zalesky A, Solowij N, Yucel M, Lubman DI, Takagi M, Harding IH, et al. Effect of long-term cannabis on axonal fibre connectivity. Brain 2012.
17. Zavitsanou K, Garrick T, Huang XF. Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 355-60. (Pubitemid 38130143)